Current location - Plastic Surgery and Aesthetics Network - Plastic surgery and medical aesthetics - SI Group’s position in Shanghai
SI Group’s position in Shanghai

SI Group’s position in Shanghai is relatively high.

Shanghai Shangshi (Group) Co., Ltd. (referred to as Shanghai Shangshi) was registered and established in 1996 with the approval of the Shanghai Municipal Government. It is the domestic subsidiary of the parent company Shanghai Industrial (Group) Co., Ltd. (referred to as SI Group). Executive Headquarters. Shanghai SIWE Co., Ltd.’s main task is to operate the state-owned assets within the SI Group and maintain and increase the value of state-owned assets.

SIIC Group was registered and established in Hong Kong in 1981 and is wholly owned by the Shanghai State-owned Assets Supervision and Administration Commission. It is Shanghai’s largest and most powerful comprehensive enterprise group abroad and the most local representative in Hong Kong. One of the largest Chinese-funded enterprises. The company's main business covers the pharmaceutical industry and commerce. In 2020, it achieved twelve-digit operating income, ranking 437th among the Fortune Global 500 in 2021 and 42nd among the top 50 global pharmaceutical companies in 2021.

Main Business

Shanghai Pharmaceutical’s total R&D investment in 2020 is in the tens of digits, with more than 1,300 R&D personnel, an overseas R&D platform, and its R&D capabilities ranking among the first echelons of domestic pharmaceutical companies. . The products cover chemical and biological drugs, modern traditional Chinese medicine and health care products, focusing on multiple therapeutic areas such as cardiovascular and cerebrovascular, mental nerves, anti-infection, immune regulation, digestive metabolism and respiratory system. It produces about 700 drug varieties and more than 20 kinds every year. dosage form.

In 2020, there were 42 products with sales exceeding nine digits, and many drugs have passed quality certifications from WHO, FDA, EU, etc. Shanghai Pharmaceuticals is the second largest national pharmaceutical distribution enterprise and the largest imported pharmaceutical service platform in China. The company's distribution network covers 31 provinces, municipalities and autonomous regions across the country, covering more than 32,000 medical institutions of various types, and has more than 100 brand chain retail pharmacies. 2000 homes.

Reference for the above content: Baidu Encyclopedia—Shanghai Shangshi (Group) Co., Ltd.